# Redhill Biopharma (RDHL) — News

RDHL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rdhl/news

## Recent headlines

- [Info Edge Board OKs ~INR 1B investment in unit 5IHL](https://www.ainvest.com/news/info-edge-board-oks-inr-1b-investment-unit-5ihl-2610) — AInvest Wire, Oct 13, 2026
  Info Edge (India) Limited has approved an investment of approximately INR 1 billion in its subsidiary, 5IHL, as part of its strategic capital allocation plans. The investment, approved by the company’s board of directors, is intended to support the subsidiary’s operational requirements and to…
- [New deal: Apotex min. C$1B debt offering in three parts](https://www.ainvest.com/news/deal-apotex-min-1b-debt-offering-parts-2609) — AInvest Wire, Sep 28, 2026
  Apotex Health Corp. has announced a minimum C$1 billion debt offering, structured in three parts, to address its financial obligations and support ongoing operations. This move comes amid a challenging financial landscape for the pharmaceutical company, which reported net loss of $38.3 million , a…
- [Redhill Biopharma - Pays $12 mln upfront for commercialization rights plus potential milestones and royalties](https://www.ainvest.com/news/redhill-biopharma-pays-12-mln-upfront-commercialization-rights-potential-milestones-royalties-2609) — AInvest Wire, Sep 1, 2026
- [Redhill Biopharma - Buys exclusive global and U.S. commercialization rights to Rebyota and Clenpiq](https://www.ainvest.com/news/redhill-biopharma-buys-exclusive-global-commercialization-rights-rebyota-clenpiq-2609) — AInvest Wire, Sep 1, 2026
  RedHill Biopharma Ltd. (Nasdaq: RDHL) has announced the acquisition of exclusive global and U.S. commercialization rights to two medical food products, Rebyota and Clenpiq, from Entera Health. This move expands RedHill’s portfolio in the gastrointestinal and infectious disease markets, aligning…
- [Redhill Biopharma - Apotex to pay $18 mln upfront plus up to $35 mln in worldwide net sales milestones](https://www.ainvest.com/news/redhill-biopharma-apotex-pay-18-mln-upfront-35-mln-worldwide-net-sales-milestones-2608) — AInvest Wire, Aug 31, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).